CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
CYNA was delisted on the 20th of October, 2016.
60 hedge funds and large institutions have $348M invested in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in 2016 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 17 closing their positions.
199% more capital invested
Capital invested by funds: $116M → $348M (+$232M)
165% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 17
88% more funds holding
Funds holding: 32 → 60 (+28)
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
75% less call options, than puts
Call options by funds: $1.1M | Put options by funds: $4.33M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BHMP
Bardin Hill Management Partners
New York
|
+$14.7M |
| 2 |
CC
Coastland Capital
Palo Alto,
California
|
+$13.1M |
| 3 |
WIC
Water Island Capital
New York
|
+$12.8M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$12.5M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$10.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$24.2M |
| 2 |
O
OrbiMed
New York
|
-$15.8M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$10.9M |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$7.71M |
| 5 |
NC
Nexthera Capital
New York
|
-$4.09M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$2K | -135 | Closed |
|
|
GBBWRPM
77
Genovese Burford & Brothers Wealth & Retirement Plan Management
Sacramento,
California
| – | -$1K | -62 | Closed |
|
CYNA Hedge Fund Activity: Q3 2016 in Review
60 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) for Q3 2016, worth a combined $348M — up 199% from $116M a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new CYNA positions and 17 closed out — a net gain of 28 holders — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Bardin Hill Management Partners, opening a new position worth an estimated $14.7M. The largest seller was Franklin Resources, exiting entirely with an estimated $24.2M sold.
- 60 institutional investors held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) as of Q3 2016, up from 32 in Q2 2016.
- Funds reported $348M of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) stock for Q3 2016, up 199% quarter-over-quarter.
- 45 funds opened new CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) positions in Q3 2016 and 17 closed out, a net change of +28 holders.
- The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) buyer in Q3 2016 was Bardin Hill Management Partners, an estimated $14.7M added.
- The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) seller in Q3 2016 was Franklin Resources, an estimated $24.2M sold.
Based on aggregated 13F filings for Q3 2016.